Posted on
26 March 2018
In Corporate
The biosimilar is one of the most important technological challenges of recent years
Pharmaceutical group Reig Jofre has entered into a strategic alliance with LeanBio, a four-year-old biotech company, to launch a new company focused on the development of biosimilars and ‘innovative’ molecules. Much like its parent companies, Syna will be headquartered in Barcelona, Spain, where LeanBio’s founder Dr Andreu Soldevila will take the helm of the new business while Gabriel Roig becomes president of the board of directors.
Bringing patients closer to biological treatments in a more sustainable way for national health systems means in addition a great social impact in a huge market